Physician

Hematology

Dr. Harold E. Windschitl, MD

Harold Windschitl is an expert in the field of Hematology. He attended Creighton University School of Medicine. Creighton University School of Medicine has a rank of 79 in research and a 78 in primary care Doctor Harold E. Windschitl, MD is also a published doctor. He has 47 publication published. The most recent publication is: Lack of effect of coumarin in women with lymphedema after treatment for breast cancer.

Publications

Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a North Central Cancer Treatment Group review of 3811 patients, N0144.
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
Proapoptotic Bad and Bid protein expression predict survival in stages II and III colon cancers.
Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.
Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers.
Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer.
Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.
Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status.
Methodologic lessons learned from hot flash studies.
Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Hematuria in sickle cell disease.
Gardners syndrome.
A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate.
Lack of effect of coumarin in women with lymphedema after treatment for breast cancer.
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.
Evaluation of intravenous 6-thioguanine as first-line chemotherapy in women with metastatic breast cancer.
Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial.
Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatm...
Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.
A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the N...
Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis.
Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluoroura...
A new biopsy needle for bone marrow.
Chronic myelogenous leukemia in Hodgkin''s disease: immunofluorescence of cells.
Primary thrombocythemia.
Achilles reflex speed during pregnancy.
Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancer.
A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.
Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer.
Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer.
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer.
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorour...
Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Tr...
A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer.
Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation.
Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Can...
Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group.
A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Centra...
A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group Study (E8188).
Symptom control trials: a 20-year experience.
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy...
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes'' B2 or C colon cancer: a North Cen...
Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation.
Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer.

Schools

Creighton University

Doctors Specialties

Internal Medicine
Hematology

Accepted Insurances

Education

University of Minnesota at Fairview
Creighton University School of Medicine

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Marie D. Guanzon, MD This Doctor is OpenDoctor Recommended.
	Dr. Christine M. Reichl, MD This Doctor is OpenDoctor Recommended.
	Dr. Daniel E. Sather, MD This Doctor is OpenDoctor Recommended.
	Dr. Nicholas F. Reuter, MD This Doctor is OpenDoctor Recommended.
	Dr. Girum L. Lemma, MD This Doctor is OpenDoctor Recommended.
	Dr. Dahlia H. Elkadi, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark D. Hauge, MD This Doctor is OpenDoctor Recommended.
	Dr. Ross F. Siemers, MD This Doctor is OpenDoctor Recommended.
	Dr. Timothy S. Yeh, MD This Doctor is OpenDoctor Recommended.
	Dr. David L. Shuster, MD
	Dr. Andrea M. Desforge, MD
	Dr. Martin M. Oken, MD This Doctor is OpenDoctor Recommended.